FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2030390610> ?p ?o ?g. }

• W2030390610 endingPage "605" @default.
• W2030390610 startingPage "597" @default.
• W2030390610 abstract "A case-control study was performed in order to determine whether expression of the progesterone receptor (PR) and/or aberrations of the PR gene contribute to the development of recurrent endometrial carcinoma. Primary tumours from 44 patients with recurrence of stage I endometrial carcinoma (patients) within 3 years after initial treatment were compared with tumours from 44 matched patients who were free of recurrence for a minimum of 3 years (controls). Paraffin wax-embedded primary tumours (n = 88) and recurrent tumours (n = 32) were analysed immunohistochemically for PR expression. A staining index (SI = 0-9) based on the staining intensity and the number of stained cells was calculated. DNA extracted from paraffin wax-embedded tissues was subjected to PCR-restriction fragment length polymorphism analysis (PCR-RFLP) for determination of the PROGINS DNA sequence alterations and the +331G/A-promoter polymorphism. Low PR expression (SI < 1.0) was observed in 7% of primary tumours derived from controls, 25% of primary tumours from patients with recurrence, and 38% of recurrent tumours. The expression of PR was significantly lower in primary tumours from patients with recurrence (SI = 4.0 +/- 0.5) than in the tumours in the control group (SI = 5.6 +/- 0.5) (T-test for paired analysis, p < 0.05). The PROGINS and +331G/A-promoter polymorphism were not related to age at diagnosis, tumour grade or myometrial invasion. The +331G/A-promoter polymorphism was present in 14% of primary tumours from patients without recurrence, compared with 17% of patients with recurrence. The PROGINS polymorphism was observed in 16% of primary tumours from patients without, and in 34% of patients with, recurrence (OR 2.6; 95% CI: 0.9-7.6). Most interestingly, patients who carried the PROGINS variant and in whom a PR-expressing tumour was diagnosed were at significantly enhanced risk of relapse (OR 4.7; 95% CI: 1.3-17.1). In conclusion, low PR expression tended to be associated with recurrent disease, and PR expression in tumours from patients carrying the PROGINS allele was predictive of the risk of recurrence." @default.
• W2030390610 created "2016-06-24" @default.
• W2030390610 creator A5016484462 @default.
• W2030390610 creator A5047876972 @default.
• W2030390610 creator A5052081262 @default.
• W2030390610 creator A5056829692 @default.
• W2030390610 creator A5068186516 @default.
• W2030390610 creator A5077325408 @default.
• W2030390610 creator A5083069711 @default.
• W2030390610 date "2005-02-22" @default.
• W2030390610 modified "2023-10-11" @default.
• W2030390610 title "Aberrations in the progesterone receptor gene and the risk of recurrent endometrial carcinoma" @default.
• W2030390610 cites W1507770182 @default.
• W2030390610 cites W1974009420 @default.
• W2030390610 cites W1985024461 @default.
• W2030390610 cites W1988091102 @default.
• W2030390610 cites W2000982161 @default.
• W2030390610 cites W2003434825 @default.
• W2030390610 cites W2007895704 @default.
• W2030390610 cites W2007956592 @default.
• W2030390610 cites W2013837963 @default.
• W2030390610 cites W2022654115 @default.
• W2030390610 cites W2025995094 @default.
• W2030390610 cites W2029158823 @default.
• W2030390610 cites W2038208040 @default.
• W2030390610 cites W2047903869 @default.
• W2030390610 cites W2058704014 @default.
• W2030390610 cites W2066796013 @default.
• W2030390610 cites W2074966947 @default.
• W2030390610 cites W2082717586 @default.
• W2030390610 cites W2090172011 @default.
• W2030390610 cites W2097409147 @default.
• W2030390610 cites W2116119303 @default.
• W2030390610 cites W2129725168 @default.
• W2030390610 cites W2144765016 @default.
• W2030390610 cites W2164696506 @default.
• W2030390610 cites W4252456312 @default.
• W2030390610 doi "https://doi.org/10.1002/path.1738" @default.
• W2030390610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15726651" @default.
• W2030390610 hasPublicationYear "2005" @default.
• W2030390610 type Work @default.
• W2030390610 sameAs 2030390610 @default.
• W2030390610 citedByCount "38" @default.
• W2030390610 countsByYear W20303906102012 @default.
• W2030390610 countsByYear W20303906102013 @default.
• W2030390610 countsByYear W20303906102014 @default.
• W2030390610 countsByYear W20303906102015 @default.
• W2030390610 countsByYear W20303906102016 @default.
• W2030390610 countsByYear W20303906102017 @default.
• W2030390610 countsByYear W20303906102018 @default.
• W2030390610 countsByYear W20303906102020 @default.
• W2030390610 countsByYear W20303906102021 @default.
• W2030390610 countsByYear W20303906102022 @default.
• W2030390610 crossrefType "journal-article" @default.
• W2030390610 hasAuthorship W2030390610A5016484462 @default.
• W2030390610 hasAuthorship W2030390610A5047876972 @default.
• W2030390610 hasAuthorship W2030390610A5052081262 @default.
• W2030390610 hasAuthorship W2030390610A5056829692 @default.
• W2030390610 hasAuthorship W2030390610A5068186516 @default.
• W2030390610 hasAuthorship W2030390610A5077325408 @default.
• W2030390610 hasAuthorship W2030390610A5083069711 @default.
• W2030390610 hasConcept C104317684 @default.
• W2030390610 hasConcept C121608353 @default.
• W2030390610 hasConcept C126322002 @default.
• W2030390610 hasConcept C142724271 @default.
• W2030390610 hasConcept C168007829 @default.
• W2030390610 hasConcept C204232928 @default.
• W2030390610 hasConcept C2777546739 @default.
• W2030390610 hasConcept C49105822 @default.
• W2030390610 hasConcept C530470458 @default.
• W2030390610 hasConcept C55493867 @default.
• W2030390610 hasConcept C71924100 @default.
• W2030390610 hasConcept C84606932 @default.
• W2030390610 hasConcept C86803240 @default.
• W2030390610 hasConcept C98717036 @default.
• W2030390610 hasConceptScore W2030390610C104317684 @default.
• W2030390610 hasConceptScore W2030390610C121608353 @default.
• W2030390610 hasConceptScore W2030390610C126322002 @default.
• W2030390610 hasConceptScore W2030390610C142724271 @default.
• W2030390610 hasConceptScore W2030390610C168007829 @default.
• W2030390610 hasConceptScore W2030390610C204232928 @default.
• W2030390610 hasConceptScore W2030390610C2777546739 @default.
• W2030390610 hasConceptScore W2030390610C49105822 @default.
• W2030390610 hasConceptScore W2030390610C530470458 @default.
• W2030390610 hasConceptScore W2030390610C55493867 @default.
• W2030390610 hasConceptScore W2030390610C71924100 @default.
• W2030390610 hasConceptScore W2030390610C84606932 @default.
• W2030390610 hasConceptScore W2030390610C86803240 @default.
• W2030390610 hasConceptScore W2030390610C98717036 @default.
• W2030390610 hasIssue "5" @default.
• W2030390610 hasLocation W20303906101 @default.
• W2030390610 hasLocation W20303906102 @default.
• W2030390610 hasOpenAccess W2030390610 @default.
• W2030390610 hasPrimaryLocation W20303906101 @default.
• W2030390610 hasRelatedWork W1977092444 @default.
• W2030390610 hasRelatedWork W2063663752 @default.
• W2030390610 hasRelatedWork W2355920994 @default.
• W2030390610 hasRelatedWork W2376996112 @default.

• next